August 17, 2021 Comments Off on New patent for Novartis drug TAFINLAR Posted in: Patent Added Annual Drug Patent Expirations for TAFINLAR Tafinlar is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Novartis drug TAFINLAR appeared first on DrugPa…
August 16, 2021 Comments Off on Upcoming workshop on generic portfolio management Posted in: Update I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…
The post Upcoming workshop on generic portfolio management appeare…
